WEST CHICAGO, Ill. — State Rep. Maura Hirschauer, D-Batavia, is continuing her commitment to cutting healthcare costs by lowering the price of costly, life saving medications through two new reforms that are now law.
“Too many people depend on insulin in their day-to-day lives for us to do nothing about outrageous price gouging by major pharmaceutical companies,” Hirschauer said. “By lowering the cost of insulin, we will help countless people manage their diabetes, and afford to do so.”
Hirschauer championed House Bill 2189 which lowered the cap on the price of insulin to $35, making it more attainable to low-income people with diabetes. Insulin helps diabetic people manage their blood sugar levels and helps turn food into energy.
Allergic reactions can turn deadly at a moment’s notice. That’s why Hirschauer fought for House Bill 3639, requiring insurance companies to cap the costs of a twin-pack of medically necessary epinephrine injectors. Due to large-scale price gouging, the cost of this life saving medication has risen dramatically, often causing those with severe allergies to navigate precariously around potentially deadly interactions.
“It is unacceptable that those with severe allergic reactions to things like nuts, household products and environmental triggers have to take their life into their hands every time they walk outside, because they can’t afford an Epi-pen,” Hirschauer said. “Epinephrine can mean the difference between life and death for many, so I am thankful to Governor Pritzker, my colleagues and all those who helped make this possible.”
For more information on this and other Hirschauer-backed legislation, visit ilga.gov.